v3.26.1
MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Common Stock Reserved for Future Issuance
The following shares of common stock are reserved for future issuance (in whole shares):
June 30, 2026December 31, 2025
Exercise of stock options and settlement of RSUs1
26,817,45414,480,386
Exercise of warrants327,8585,304,255
Conversion of preferred stock—67,992,679
27,145,31287,777,320
_______________
(1)The December 31, 2025 balance has been adjusted from previously reported amounts to reflect an immaterial reduction of 377,671 options. This adjustment did not have a material impact on the Company's previously issued consolidated financial statements, share-based compensation expense, or earnings per share.
Schedule of Convertible Preferred Stock
Prior to the completion of the IPO, as of December 31, 2025, the Company's existing amended and restated certificate of incorporation authorized the issuance of 77,003,772 shares of preferred stock par value $0.0001 per share, the details of which are presented below (in whole shares):
As of December 31, 2025
AuthorizedOutstanding
Series A-17,312,5007,312,500
Series A-212,680,90812,680,908
Series A-34,953,7464,953,746
Series B11,574,84111,574,841
Series C6,960,4396,960,439
Series D12,857,72012,857,720
Series D-16,085,1616,085,161
Series E14,578,4575,567,364
Total77,003,77267,992,679
Summary of Warrants Outstanding
As of June 30, 2026, the following equity classified warrants to issue stock of the Company remain outstanding:
Original Issuance DateExpiration DateExercise PriceWarrants
Issued		Warrants
Currently
Exercisable
June 2017June 2027$0.2347,700—
May 2018June 2027$0.2315,900—
May 2019March 2029$0.7725,428—
May 2019March 2029$0.7725,429—
February 2020February 2032$2.29112,240—
February 2020February 2032$2.29112,240112,240
February 2020February 2032$2.2956,12042,027
March 2024March 2034$2.3164,998—
December 2025December 2035$11.42173,591173,591
633,646327,858